Aduhelm, a medication to treat mild stages of Alzheimer's disease, was launched by Biogen in June 2021. The approval was highly...

Die Reduktion einer Markteinführung auf Zulassungsthemen führt regelmäßig zum Misserfolg.

Young companies regularly discover that their product, their innovation does not generate the sales they had hoped for. The sobering...